BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24482067)

  • 1. Treatment of BK viremia after renal transplantation: are fluoroquinolones a false dawn?
    Anwar S; Brennan DC
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):445-7. PubMed ID: 24482067
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial.
    Lee BT; Gabardi S; Grafals M; Hofmann RM; Akalin E; Aljanabi A; Mandelbrot DA; Adey DB; Heher E; Fan PY; Conte S; Dyer-Ward C; Chandraker A
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):583-9. PubMed ID: 24482066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
    Shah T; Vu D; Naraghi R; Campbell A; Min D
    Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
    Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel treatment regimen for BK viremia.
    Zaman RA; Ettenger RB; Cheam H; Malekzadeh MH; Tsai EW
    Transplantation; 2014 Jun; 97(11):1166-71. PubMed ID: 24531848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study.
    Sood P; Senanayake S; Sujeet K; Medipalli R; Zhu YR; Johnson CP; Hariharan S
    Transplantation; 2012 Oct; 94(8):814-21. PubMed ID: 23018881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients.
    Tohme FA; Kalil RS; Thomas CP
    Transpl Infect Dis; 2015 Feb; 17(1):66-72. PubMed ID: 25582442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viremia Negativization After BK Virus Infection in Kidney Transplantation: A National Bicentric Study.
    Garofalo M; Pisani F; Lai Q; Montali F; Nudo F; Gaeta A; Russo G; Natilli A; Poli L; Martinelli C; Binda B; Pretagostini R
    Transplant Proc; 2019 Nov; 51(9):2936-2938. PubMed ID: 31711578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral therapy for polyomavirus-associated nephropathy after renal transplantation.
    Hilton R; Tong CY
    J Antimicrob Chemother; 2008 Nov; 62(5):855-9. PubMed ID: 18658193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Frequency of BK Virus-Specific Polyfunctional CD8+ T Cells Predict Successful Control of BK Viremia After Kidney Transplantation.
    Schaenman JM; Korin Y; Sidwell T; Kandarian F; Harre N; Gjertson D; Lum EL; Reddy U; Huang E; Pham PT; Bunnapradist S; Danovitch GM; Veale J; Gritsch HA; Reed EF
    Transplantation; 2017 Jun; 101(6):1479-1487. PubMed ID: 27391197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.
    Cabello V; Margarit N; Díaz Pedrero M; Bernal G; Pereira P; Gentil MA
    Transplant Proc; 2008 Nov; 40(9):2930-2. PubMed ID: 19010151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
    Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
    Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.
    Vu D; Shah T; Ansari J; Naraghi R; Min D
    Transplant Proc; 2015 Mar; 47(2):394-8. PubMed ID: 25769580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
    Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
    Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
    Pape L; Tönshoff B; Hirsch HH;
    Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
    Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
    Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation.
    Papanicolaou GA; Lee YJ; Young JW; Seshan SV; Boruchov AM; Chittick G; Momméja-Marin H; Glezerman IG
    Am J Kidney Dis; 2015 May; 65(5):780-4. PubMed ID: 25600489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide for polyomavirus type BK nephropathy.
    Williams JW; Javaid B; Kadambi PV; Gillen D; Harland R; Thistlewaite JR; Garfinkel M; Foster P; Atwood W; Millis JM; Meehan SM; Josephson MA
    N Engl J Med; 2005 Mar; 352(11):1157-8. PubMed ID: 15784677
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation.
    Thölking G; Schmidt C; Koch R; Schuette-Nuetgen K; Pabst D; Wolters H; Kabar I; Hüsing A; Pavenstädt H; Reuter S; Suwelack B
    Sci Rep; 2016 Aug; 6():32273. PubMed ID: 27573493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.